Table 2.
Characteristics | Total | Adherence to IFA tablets, n (%) Yes (%) | Prevalence ratio with CI |
---|---|---|---|
Total | 340 | 217 (63.82) | - |
Gravida status | |||
Primi | 200 (58.8) | 138 (69) | 1.22 (1.02-1.45) |
Multi | 140 (41.2) | 79 (56.4) | 1 |
Number of abortions | |||
Nil | 307 (90.3) | 198 (64.5) | 1 |
One | 26 (07.6) | 15 (57.7) | 0.89 (0.63-1.25) |
Two or more | 7 (02.1) | 4 (57.1) | 088 (0.46-1.69) |
Received health education | |||
Yes | 222 (65.3) | 150 (67.6) | 1.23 (1.03-1.47) |
No | 118 (34.7) | 67 (56.8) | 1 |
Anemia status in the first trimester | |||
Anemic | 242 (71.2) | 136 (58.6) | 1 |
Nonanemic | 98 (28.8) | 81 (75) | 1.27 (1.09-1.49) |
Anemia status in the third trimester | |||
Anemic | 232 (68.2) | 152 (62.8) | 1 |
Nonanemic | 108 (31.8) | 65 (66.3) | 1.05 (0.88-1.25) |
Side effects to IFAS | |||
Present | 232 (68.2) | 13 (22.8) | 1 |
Absent | 108 (31.8) | 204 (72.1) | 3.16 (1.95-5.12) |
CI=Confidence interval, IFA=Iron and folic acid, IFAS=IFA supplementation